We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Premier Biomedical Inc (PK) | USOTC:BIEI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0001 | 8.33% | 0.0013 | 0.0012 | 0.0014 | 0.0014 | 0.0012 | 0.0013 | 366,656 | 20:14:36 |
|
UNITED STATES
|
|
|
SECURITIES AND EXCHANGE
COMMISSION
|
SEC File No:
000-54563
|
|
Washington, D.C. 20549
|
CUSIP No: 74048 K 10
4
|
◻
|
Transition report on Form 10-K
|
◻
|
Transition report on Form 20-F
|
◻
|
Transition report on Form 11-K
|
◻
|
Transition report on Form 10-Q
|
◻
|
Transition report on Form N-SAR
|
Nothing in this form shall
be construed to imply that the Commission has verified any
information contained herein.
|
PART 1 -- REGISTRANT
INFORMATION
|
|
Premier Biomedical,
Inc.
|
Full Name of Registrant
|
|
Former Name if Applicable
|
|
P.O. Box
25
|
Address of Principal Executive Office
(
Street and
Number)
|
|
Jackson Center, PA
16133
|
City, State and Zip Code
|
☒
|
|
(a)
|
The reasons described in reasonable detail in
Part III of this form could not be eliminated without unreasonable
effort or expense;
|
|
(b)
|
The subject annual report, semi-annual
report, transition report on Form 10-K, Form 20-F, Form 11-K, Form
N-SAR or Form N-CSR, or a portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due
date; or the subject quarterly report or transition report on Form
10-Q, or subject distribution report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day
following the prescribed due date; and
|
|
|
(c)
|
The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if
applicable.
|
William
Hartman
|
|
814
|
|
786-8849
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
Premier Biomedical, Inc.
|
(Name of Registrant as Specified in
Charter)
|
Date August 14, 2018
|
By
|
/s/ William A.
Hartman
|
|
|
|
William A. Hartman
|
|
|
|
Chief Executive Officer
|
|
|
1 Year Premier Biomedical (PK) Chart |
1 Month Premier Biomedical (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions